Diagnostic value of MPO and lysozyme antibodies in acute leukemia. Implications for the definition of FAB subtypes using a flow cytometric approach in combination with different permeabilising methods.
Latorraca
A
A
Section of Hematology, University of Ferrara, Italy.
Lanza
F
F
Ferrari
L
L
Castoldi
G L
GL
D000208:Acute Disease; D000906:Antibodies / Q000378:metabolism; D002463:Cell Membrane Permeability / Q000187:drug effects*; D005434:Flow Cytometry / Q000379:methods*; D019085:Fluorescent Antibody Technique, Direct; D006801:Humans; D007951:Leukemia, Myeloid / Q000145:classification / Q000201:enzymology*; D009113:Muramidase / Q000276:immunology*; D009195:Peroxidase / Q000276:immunology*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000145:classification / Q000201:enzymology
D000906:Antibodies; D009195:Peroxidase; D009113:Muramidase